Mucoepidermoid carcinoma other imaging findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Mucoepidermoid carcinoma}}
{{Mucoepidermoid carcinoma}}
{{CMG}}{{{Badria}} , {{MV}}
{{CMG}} {{AE}} {{{Badria}} , {{MV}}


==Overview==
==Overview==

Revision as of 14:59, 22 January 2019

Mucoepidermoid carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mucoepidermoid Carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mucoepidermoid carcinoma other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mucoepidermoid carcinoma other imaging findings

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mucoepidermoid carcinoma other imaging findings

CDC on Mucoepidermoid carcinoma other imaging findings

Mucoepidermoid carcinoma other imaging findings in the news

Blogs on Mucoepidermoid carcinoma other imaging findings

Directions to Hospitals Treating Mucoepidermoid carcinoma

Risk calculators and risk factors for Mucoepidermoid carcinoma other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: {Badria Munir M.B.B.S.[2] , Maria Fernanda Villarreal, M.D. [3]

Overview

There are no other imaging findings associated with mucoepidermoid carcinoma.

Other Imaging Findings

F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) scanning can be used to plan treatment of salivary gland malignancies by detecting lymph node metastases that require a neck dissection or by finding distant metastases that may not have caused abnormalities in routine blood work. This is most useful when combined with CT scanning.

Technetium-99m (Tc-99m) pertechnetate scintigraphy with lemon juice stimulation can be used to diagnose Warthin tumors with correlation between tumor size and Tc-99m uptake.[1]


There are no other imaging findings associated with mucoepidermoid carcinoma.[2]

References

  1. Krishnamurthy, Arvind; Ramshankar, Vijayalakshmi; Majhi, Urmila (2016). "Role of fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography in management of pulmonary mucoepidermoid carcinomas and review of literature". Indian Journal of Nuclear Medicine. 31 (2): 128. doi:10.4103/0972-3919.178264. ISSN 0972-3919.
  2. Mucoepidermoid carcinoma. Radiopedia. Dr Frank Gailliard. http://radiopaedia.org/articles/mucoepidermoid-carcinoma-of-salivary-glands Accessed on February 17, 2016